AzTrials
AzTrials

Hypertensive EmergencyNCT06201572

The Value of TOI in Evaluating Renal Function Damage in Hypertensive Emergency Patients

An observational study of Hypertensive Emergency, run by The Affiliated Hospital of Hangzhou Normal University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

TOI was used to measure heart rate, respiration, blood pressure, heart rate variability and psychological stress. At the same time, the patient's urine protein, creatinine, urea nitrogen and other indicators were detected. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Hypertensive Emergency
What is being tested?
The relationship between TOI composite index and renal function in hypertensive emergency patients was compared
How many people
300 participants
Where
No sites listed yet
Study dates
1 Feb 2024to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Adult, Older adult

Study population: Patients hospitalized for acute hypertension from January 2022 to December 2024 with onset time <48 hours and blood pressure measured by standard sphygmomanometer: Systolic blood pressure (SBP)>180mmHg and/or diastolic blood pressure (DBP)>120mmHg, age >18 years old, gender, stable vital signs, good compliance, complete and reliable medical records.

Who may be able to join

  • Systolic blood pressure (SBP)>180mmHg
  • Diastolic blood pressure (DBP)>120mmHg

Who cannot join

  • Severe head and facial skin injury
  • Cerebral hemorrhage or severe shock after admission
  • Patients who insist on refusing to participate in this clinical tria
  • Patients who could not participate in the study for other reasons.

About this study

Official title: The Value of Smartphone-based Optical Blood Spectrum Imaging (TOI) in Evaluating Renal Function Damage in Hypertensive Emergency Patients

TOI was used to measure heart rate, respiration, blood pressure, heart rate variability and psychological stress. At the same time, the patient's urine protein, creatinine, urea nitrogen and other indicators were detected. According to different renal function, they were divided into observation group and control group, and 100 general inpatients with renal insufficiency were selected as positive control group. The relationship between TOI composite index and renal function in hypertensive emergency patients was compared.

Read the detailed description

TOI technique was used to measure the heart rate, respiration, blood pressure, heart rate variability, psychological pressure, etc. At the same time, the urine protein, creatinine, urea nitrogen and other results of these patients were measured. According to the different renal function, they were divided into observation group and control group, and 100 ordinary hospitalized patients with renal insufficiency were selected as positive control group. The relationship between TOI composite index and renal function in hypertensive emergency patients was compared. The data management platform provides intelligent management of patients' out-of-hospital follow-up, and the dynamic physiological indicators and psychological assessment data of patients are mastered through the hospital port, so as to provide telemedicine guidance for patients, so as to improve the prognosis of hypertensive emergency patients.

Being tested
The relationship between TOI composite index and renal function in hypertensive emergency patients was compared
Medical subject headings
Hypertensive Crisis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The relationship between TOI composite index and renal function in hypertensive emergency patients was comparedOther

    The relationship between TOI composite index and renal function in hypertensive emergency patients was compared. The data management platform provides intelligent management of patients' out-of-hospital follow-up, and the dynamic physiological indicators and psychological assessment data of patients are mastered through the hospital port, so as to provide telemedicine guidance for patients, so as to improve the prognosis of hypertensive emergency patients.

Study groups in NCT06201572
Study groupRoleWhat they receive
Observation groupNot described
Receives: Other: The relationship between TOI composite index and renal function in hypertensive emergency patients was compared
Control groupNot described
Positive control groupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. blood pressure

    Both systolic and diastolic Blood Pressure levels of enrolled patients

    Measured: 2023-12-01 to 2024-12-31

  2. creatinine

    creatinine levels of enrolled patients

    Measured: 2023-12-01 to 2024-12-31

  3. urea nitrogen

    urea nitrogen levels of enrolled patients

    Measured: 2023-12-01 to 2024-12-31

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2024
  2. Study start1 Feb 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06201572
Sponsor's protocol ID
AH-2023-001
Status last verified
Nov 2023
First submitted
2 Jan 2024
Last updated
22 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypertensive Emergency, run by The Affiliated Hospital of Hangzhou Normal University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

blood pressure (time frame: 2023-12-01 to 2024-12-31). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in